Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
Research output: Contribution to journal › Article › peer-review
Colleges, School and Institutes
We report on a 36-year-old woman treated with the anti PD-1 antibody Pembrolizumab for metastatic cutaneous melanoma in the first line setting. She achieved a complete response and then relapsed with metastases to the vitreous cavity with an associated angiographically determined retinal vasculitis. Vitreous metastasis without choroidal involvement is unusual and may be due to individual cell extravasation, vitreous hemorrhage containing malignant cells, or direct spread through the optic nerve. This finding highlights the need for immune sanctuary sites to be monitored in the presence of PD-1 inhibition and we hypothesize that the use of PD-1 inhibitor potentiated the patient's angiographically determined retinal vasculitis.
|Number of pages||4|
|Journal||Journal for ImmunoTherapy of Cancer|
|Publication status||Published - 16 Dec 2014|
- Vitreous metastasis, Melanoma, Retinal vasculitis, PD-1 inhibitor, Melanoma-associated Retinopathy (MAR)